![Bill Fleming](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bill Fleming
Direttore Finanziario/CFO presso Ingenox Therapeutics Ltd.
Provenienza dei contatti di primo grado di Bill Fleming
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Ingenox Therapeutics Ltd.
![]() Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue.
7
| Private Company | Hospital/Nursing Management | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bill Fleming tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
Oxford Cancer Biomarkers Ltd.
![]() Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Hospital/Nursing Management | Founder Founder | |
University of Oxford | College/University | Graduate Degree Corporate Officer/Principal | |
STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member | |
Northland Capital Partners Ltd.
![]() Northland Capital Partners Ltd. Investment Banks/BrokersFinance Northland Capital Partners Ltd. provides investment banking services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1991. Robert Alan Johnson has been the CEO of the company since 2010. | Investment Banks/Brokers | Director/Board Member | |
MEDIGENE AG | Biotechnology | Director/Board Member | |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Oxfordshire Biotechnet Ltd.
![]() Oxfordshire Biotechnet Ltd. Investment ManagersFinance Oxfordshire Biotechnet Ltd. is a venture capital fund. | Investment Managers | Director/Board Member | |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
Kleinwort Benson Ltd. (New York) | Director/Board Member | ||
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Pneumagen Ltd.
![]() Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Biotechnology | Chairman | |
Pneumagen (Holdings) Ltd. | Director/Board Member | ||
OxOnc Development LP
![]() OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Corporate Officer/Principal | |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
Adaptimmune Ltd.
![]() Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
Adprotech Pharmaceuticals, Inc. | Director/Board Member | ||
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
ADVANCED MEDICAL SOLUTIONS GROUP PLC | Medical Specialties | Director/Board Member | |
Oxagen Ltd.
![]() Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Anthra Pharmaceuticals, Inc.
![]() Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Medical Distributors | Director/Board Member | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
VERNALIS | Pharmaceuticals: Major | Director of Finance/CFO | |
Commerzbank Finance Ltd.
![]() Commerzbank Finance Ltd. Investment Banks/BrokersFinance Part of Commerzbank AG, Commerzbank Finance Ltd. is a British company that provides securities brokerage services. The company is based in London, UK. Commerzbank Finance was founded in 1955. | Investment Banks/Brokers | Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder | |
Axellis, Inc.
![]() Axellis, Inc. Medical DistributorsDistribution Services Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK | Medical Distributors | Director/Board Member | |
Argonaut Therapeutics Ltd.
![]() Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Operating Officer |
Statistiche
Distribuzione geografica
Regno Unito | 32 |
Stati Uniti | 7 |
Germania | 2 |
Svezia | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 22 |
Finance | 8 |
Commercial Services | 4 |
Health Services | 3 |
Miscellaneous | 3 |
Posizioni
Director/Board Member | 43 |
Chief Executive Officer | 8 |
Chairman | 8 |
Corporate Officer/Principal | 7 |
Founder | 5 |
Contatti più connessi
Insiders | |
---|---|
James Noble | 39 |
David Kerr | 5 |
Nick la Thangue | 4 |
Collette Coll | 3 |
Simon Kerry | 1 |
Richard Taylor | 1 |
Nick Dixon-Clegg | 1 |
- Borsa valori
- Insiders
- Bill Fleming
- Connessioni Società